Celldex Therapeutics
CLDX
#4999
Rank
S$1.67 B
Marketcap
$25.29
Share price
-1.79%
Change (1 day)
-49.81%
Change (1 year)

EPS for Celldex Therapeutics (CLDX)

EPS in 2023 (TTM): -$3.27

According to Celldex Therapeutics's latest financial reports the company's current EPS (TTM) is -$3.16. In 2022 the company made an earnings per share (EPS) of -$3.14 a decrease over its 2021 EPS that were of -$2.16.

EPS history for Celldex Therapeutics from 1996 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$3.274.08%
2022-$3.1445.73%
2021-$2.16-23.36%
2020-$2.81-41.05%
2019-$4.77-76.95%
2018-$20.7145.03%
2017-$14.28-42.54%
2016-$24.86-3.82%
2015-$25.84-0.76%
2014-$26.0429.41%
2013-$20.120%
2012-$20.12-9.73%
2011-$22.291312.5%
2010-$1.58-95.79%
2009-$37.45-49.64%
2008-$74.37-82.64%
2007-$428.49-44.98%
2006-$778.851270.83%
2005-$56.8233.33%
2004-$42.61-10%
2003-$47.35-16.67%
2002-$56.82-38.46%
2001-$92.33-4.88%
2000-$97.06-81.66%
1999-$529.09-87.2%
1998-$4,132206.39%
1997-$1,34913.02%
1996-$1,193

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$5.27 67.08%๐Ÿ‡บ๐Ÿ‡ธ USA
-$1.12-64.58%๐Ÿ‡บ๐Ÿ‡ธ USA
-$15.89 403.33%๐Ÿ‡บ๐Ÿ‡ธ USA
$18.61-689.58%๐Ÿ‡บ๐Ÿ‡ธ USA
$2.45-177.50%๐Ÿ‡บ๐Ÿ‡ธ USA
$4.60-245.86%๐Ÿ‡ฌ๐Ÿ‡ง UK
-$0.75-76.25%๐Ÿ‡บ๐Ÿ‡ธ USA